Fabiano V, Mameli C, Zuccotti GV. Paediatric pharmacology: remember the excipients. Pharmacol Res. 2011;63:362–5.

Article  CAS  PubMed  Google Scholar 

Salunke S. Thesis. University College London; London, UK: 2017. Development and Evaluation of Database of Safety and Toxicity of Excipients for Paediatrics (STEP Database). https://discovery.ucl.ac.uk/id/eprint/1546094/ Accessed on 1 August 2023.

Salunke S, Giacoia G, Tuleu C. The STEP (safety and toxicity of excipients for paediatrics) database. Part 1-A need assessment study. Int J Pharm. 2012;435:101–11.

Article  CAS  PubMed  Google Scholar 

Soremekun R, Ogbuefi I, Aderemi-Williams R. Prevalence of ethanol and other potentially harmful excipients in pediatric oral medicines: survey of community pharmacies in a Nigerian City. BMC Res Notes. 2019;12:1–5.

Article  Google Scholar 

Nakama K, Dos Santos R, Serpa P, et al. Organoleptic excipients used in pediatric antibiotics. Arch Pédiatrie. 2019;26:431–6.

Article  CAS  Google Scholar 

Kriegel C, Festag M, Kishore RS, et al. Pediatric safety of polysorbates in drug formulations. Children. 2019;7:1.

Article  PubMed  PubMed Central  Google Scholar 

Akinmboni TO, Davis NL, Falck AJ, et al. Excipient exposure in very low birth weight preterm neonates. J Perinatol. 2018;38:169–74.

Article  CAS  PubMed  Google Scholar 

Fister P, Urh S, Karner A, et al. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia. J Matern Fetal Neonatal Med. 2015;28:2053–61.

Article  CAS  PubMed  Google Scholar 

Cuzzolin L. Neonates exposed to excipients: concern about safety. J Pediatr and Neonat Individualized Med. 2018;7: e070112.

Google Scholar 

Nellis G, Metsvaht T, Varendi H, et al. ESNEE consortium. Potentially harmful excipients in neonatal medicines: a pan-European observational study. Arch Dis Child. 2015;100:694–9.

Article  PubMed  Google Scholar 

Koshi B, Grapci AD, Nebija D, et al. The potentially harmful excipients in prescribed medications in a Neonatal Intensive Care Unit in Kosovo and available safer alternatives. Turk J Pediatr. 2022;64:49–58.

Article  PubMed  Google Scholar 

Lass J, Naelapää K, Shah U, et al. Hospitalised neonates in Estonia commonly receive potentially harmful excipients. BMC Pediatr. 2012;12:136.

Article  PubMed  PubMed Central  Google Scholar 

Saito J, Nadatani N, Setoguchi M, et al. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan. J Pharm Health Care Sci. 2021;7:23.

Article  PubMed  PubMed Central  Google Scholar 

Sviestina I, Mozgis D. A retrospective and observational analysis of harmful excipients in medicines for hospitalised neonates in Latvia. Eur J Hosp Pharm. 2018;25:176–82.

Article  PubMed  Google Scholar 

Garcia-Palop B, Polanco EM, Ramirez CC, Poy MJC. Harmful excipients in medicines for neonates in Spain. Int J Clin Pharm. 2016;38:238–42.

Article  PubMed  Google Scholar 

Souza A Jr, Santos D, Fonseca S, et al. Toxic excipients in medications for neonates in Brazil. Eur J Pediatr. 2014;173:935–45.

Article  CAS  PubMed  Google Scholar 

Salunke S, Brandys B, Giacoia G, et al. The STEP (safety and toxicity of excipients for paediatrics) database: part 2—the pilot version. Int J Pharm. 2013;457:310–22.

Article  CAS  PubMed  Google Scholar 

Cañete CR, García MP, García BP, et al. Formulación magistral y excipientes en pediatría. El Farma-céutico Hospitales. 2018;213:22–8.

Google Scholar 

Parneli C, Srivari Y, Meiki Y, et al. Pharmaceutical excipients and paediatric formulations. Chem Today. 2012;30:56–61.

Google Scholar 

Peiré MAG (2019) Farmacología Pediátrica, 1st ed, Ediciones Journal: Ciudad Autónoma de Buenos Aires, Argentina

Rowe RC, Sheskey PJ, Owen SC. Handbook of Pharmaceutical Excipients. 6th ed. London: Pharmaceutical Press; 2006.

Google Scholar 

Valeur KS, Hertel SA, Lundstrøm KE, et al. Safe excipient exposure in neonates and small children—Protocol for the SEEN project. Dan Med J. 2017;64:A5324.

PubMed  Google Scholar 

Horinek EL, Kiser TH, Fish DN, et al. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Ann Pharmacother. 2009;43:1964–71.

Article  CAS  PubMed  Google Scholar 

Shehab N, Lewis CL, Streetman DD, et al. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med. 2009;10:256–9.

Article  PubMed  Google Scholar 

Mulla H, Yakkundi S, McElnay J, et al. An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonates. Pharm Res. 2015;32:1084–93.

Article  CAS  PubMed  Google Scholar 

Evaluation of certain food additives and contaminants. Forty-sixth report of the Joint FAO/WHO expert committee on food additives. World Health Organ Tech Rep Ser. 1997;868:1–69.

Google Scholar 

Aguilar F, Crebelli R, Domenico AD, et al. Scientific opinion on the re-evaluation of benzoic acid (E 210), sodium benzoate (E 211), potassium benzoate (E 212) and calcium benzoate (E 213) as food additives. EFSA J. 2016;14:4433.

Google Scholar 

SCF (Scientific Committee on Food) (2023) Opinion of the Scientific Committee on Food on Benzoic acid and its salts, SCF/CS/ADD/CONS/48 Final, September 2002. https://food.ec.europa.eu/system/files/2020-12/sci-com_scf_out137_en.pdf Accessed 10 Aug 2023.

European Medicines Agency (2023) Questions and answers on benzoic acid and benzoates used as excipients in medicinal products for human use EMA/CHMP/508189/2013. https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-benzoic-acid-benzoates-used-excipients-medicinal-products-human-use_en.pdf Accessed 10 Aug 2023.

Hannah K, John F. Formulations for children: problems and solutions. Br J Clin Pharmacol. 2015;79:405–18.

Article  Google Scholar 

Rowe RC. Handbook of Pharmaceutical Excipients. 7th ed. London: Pharmaceutical Press; 2012.

Google Scholar 

Gold S (2006) Reflection paper: formulations of choice for the pediatric population. Eur Medic Agen. 2006. https://www.ema.europa.eu/en/formulations-choice-paediatric-population. Accessed 10 Aug 2023.

Cronin CM, Brown DR, Ahdab-Barmada M. Risk factors associated with kernicterus in the newborn infant: importance of benzyl alcohol exposure. Am J Perinatol. 1991;8:80–5.

Article  CAS  PubMed  Google Scholar 

Walsh J, Mills S. Conference report: formulating better medicines for children: 4th European paediatric formulation initiative conference. Ther Deliv. 2013;4:21–5.

Article  CAS  PubMed  Google Scholar 

World Health Organizations (2012) Development of Pediatric Medicines: Points to Consider in the Formulation. Geneva: WHO technical report series 2012. https://apps.who.int/medicinedocs/en/m/abstract/Js19833en. Accessed 10 Aug 2023.

Younes M, Aquilina G, Castle L, et al. Scientific opinion on the re-evaluation of benzyl alcohol (E 1519) as food additive. EFSA J. 2019;17:5876–901.

Google Scholar 

Rouaz K, Chiclana-Rodríguez B, Nardi-Ricart A, et al. Excipients in the paediatric population: a review. Pharmaceutics. 2021;13:387.

Article  CAS  PubMed  PubMed Central  Google Scholar 

European Medicines Agency (2023) Questions and answers on benzyl alcohol used as an excipient in medicinal products for human use EMA/CHMP/508188/2013. https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-benzyl-alcohol-used-excipient-medicinal-products-human-use_en.pdf. Accessed 10 August 2023.

Hiller JL, Benda GI, Rahatzad M, et al. Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very low birth weight infants. Pediatrics. 1986;77:500–6.

Article  CAS  PubMed  Google Scholar 

Jardine D, Rogers K. Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in preterm infants. Pediatrics. 1989;83:153–60.

CAS  PubMed  Google Scholar 

Benda GI, Hiller JL, Reynolds JW. Benzyl alcohol toxicity: impact on neurologic handicaps among surviving very low birth weight infants. Pediatrics. 1986;77:507–12.

Article  CAS  PubMed  Google Scholar 

Mark K, Kelly DK, Kent EV. Treatment of Infectious Diseases. In: Mark K, Kelly DK, Kent EV, editors. Elsevier’s Integrated Review Pharmacology. 2nd ed. Philadelphia: Elsevier; 2012. p. 41–78.

Google Scholar 

European Medicines Agency (2023) Information for the package leaflet regarding ethanol used as an excipient in medicinal products for human use EMA/CHMP/43486/2018 Corr. 1. https://www.ema.europa.eu/en/documents/scientific-guideline/information-package-leaflet-regarding-ethanol-used-excipient-medicinal-products-human-use_en.pdf Accessed on 10 August 2023.

Sun C, Nie Y, Cui X, et al. Neonatal acute ethanol intoxication during the epidemic of COVID-19: a case report. BMC Pediatr. 2022;22:53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nahata MC. Safety of “inert” additives or excipients in paediatric medicines. Arch Dis Child Fetal Neonatal Ed. 2009;94:F392–3.

Article  PubMed  Google Scholar 

LaHood AJ, Kok SJ. Ethanol Toxicity. Tampa: StatPearls Publishing; 2023.

Google Scholar 

EFSA Ans Panel (EFSA Panel on Food Additives and Nutrient Sources added to Food), Mortensen A, Aguilar F, Crebelli R, Di Domenico A, Dusemund B, Frutos MJ, Galtier P, Gott D, Gundert-Remy U, Leblanc J-C, et al. Scientific opinion on the re-evaluation of glycerol (E 422) as a food additive. EFSA J. 2017;15:4720–84.

Google Scholar 

Noel KM, Carolyn C, Pinar TO, et al. Glycerol intolerance in a child with intermittent hypoglycemia. J Pediatrics. 1975;86:43–9.

Article  Google Scholar 

Tildon J, Ozand P, Karahasan A, et al. Biochemical Studies of Glycerol Neurotoxicity. Pediatr Res. 1976;10:895.

Article  Google Scholar 

Katayama S, Nunomiya S, Wada M, et al. Hyperlactatemia caused by intra-venous administration of glycerol: A case study. Indian J Crit Care Med. 2012;16:241–4.

Article  PubMed  PubMed Central  Google Scholar